Roychoudhuri Lab
@RoychoudhuriLab
Followers
2K
Following
4K
Statuses
2K
Professor of Cancer Immunology and Immunotherapy
University of Cambridge, UK
Joined October 2018
Really lovely opportunity to discuss cancer immunology and life in science on @ImmunoPodcast. Thanks for the opportunity to discuss our work @CamPathology @CRUKCamCentre
We have a new episode out! Tune in to hear Dr. Rahul Roychoudhuri (@RoychoudhuriLab) discuss enhancing #CellTherapy with new payloads and targeting cancer cells during #metastasis. Listen now:
1
3
24
RT @WTKLAB: JOB ALERT We are seeking a Computational Research Assistant or Research Associate to help drive an ambitious multiomics agei…
0
5
0
Fantastic talk in #cancer #immunology by @giampazolias as part of the Cambridge Immunology Network seminar series @Cambridgeimmuno
0
2
30
See you tonight at the Panton Arms for science conversation and free #pizza!
Last chance to join @CRUKCamCellBio for their 2nd Precision Pints event! Join for short talks from cancer researchers, pizza and discussion! Mon 16 Dec, 7-8.30pm Panton Arms, CB2 1HL Book your free tickets here: @RoychoudhuriLab @CamBiochem
0
0
2
RT @sarah_h_ross: In June '24: At the moment of T cell activation, the presence, or lack, of nuclear envelope invaginations, which gather o…
0
46
0
RT @TuomasTammela: Several years in the making (and aging), @Xueqian_Zhuang 's study on aging is out today @Nature. She finds, surprisingly…
0
114
0
RT @MauroCorradoBio: Circulating tumor-reactive KIR+CD8+ T cells suppress anti-tumor immunity in patients with melanoma
0
16
0
RT @Cambridge_SBS: We are recruiting leading scientists in the Biological Sciences to join our interdisciplinary and innovative research co…
0
8
0
RT @Katia_Faliti: ✨ Ever wondered why B cells are so fond of IL-2? Wonder no more! Our study is finally published!🔍📑
0
12
0
RT @Tetsuo_Hase: Thrilled to share our story out in Nature Immunology and being chosen for the cover of Dec issue. Our question was “why j…
0
10
0
RT @SGoswamiMDPhD: One of the best review writing experiences with @kepauken@IamLinghua, @PamSharmaMDPhD Thanks for the invitation @…
0
26
0
RT @MetastasisRS: This month, we honor those affected by pancreatic cancer and stand with the fighters. See recent publication from former…
0
9
0
RT @ItaiYanai: Is basic science undervalued? David Glanzman talks about the decline of 'middle class' labs and that "there is no empirical…
0
54
0
RT @JezCarlton: UK Membrane Trafficking 2024 Who doesn’t like a deadline that gets brought forward? Please register by 3rd December - Kin…
0
9
0
RT @JonathanHeeney: And a tribute to the incredible Darwin family and their legacy @DarwinCollege @Cambridge_Uni . Honoured to be a fellow…
0
1
0
Hilarious!
0
0
3
RT @Ruffell_Lab: Thrilled to share our story out in Cancer Cell, led by the amazing Kay Hanggi (now on the job market). We show that necrot…
0
21
0
Couldn’t agree more - so many major ideas have arisen during conversation. Co-leadership within labs or joint labs makes perfect sense
Would you prefer to lead a lab alone or together with a science buddy? How interesting would be a research institute where joint labs are the standard?!
0
0
5
RT @CRUKCamCellBio: Listen to @RoychoudhuriLab, co lead of the Fundamental Biology of Cancer programme talking about his work in the @Immun…
0
2
0
Not the only example of “immunoregulatory cell death”.. cool paper!
People, the IL-1 pathway is SO RELEVANT in cancer 🔥🔥 IL-1a released from dying tumor cells dampens anti-tumor immunity by recruiting immune suppressive myeloid cells - this limits efficacy of chemo and ICB by Brian Ruffel in @Cancer_Cell
0
0
2